Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction

NCT01593787 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension With Renal Dysfunction

Interventions

DRUG: LCZ696

Sponsor

Novartis Pharmaceuticals